JAK2V617F inhibitor therapy(Eilean Therapeutics)

N/A

Report date: 2024/10/10 11:20:26
NME

Base Information

Drug NameJAK2V617F inhibitor therapy(Eilean Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJAK2 V617F inhibitors
TargetsJAK2 V617F
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A